The circular RNA hsa_circ_000780 as a potential molecular diagnostic target for gastric cancer

• Published in: BMC medical genomics 2021-11, Vol.14 (1), p.282-282, Article 282
• Main Authors: Song, Jian, Yu, Shuyong, Zhong, Dunjing, Yang, Weizhong, Jia, Zhen, Yuan, Guihong, Li, Ping, Zhang, Ronglin, Li, Yini, Zhong, Guobing, Chen, Zhaowei
• Format: Article
• Language: English
• Subjects: Binding sites; Biological markers; Biomarkers, Tumor - genetics; Carcinoembryonic antigen; Cardiovascular disease; Circular RNA; Diagnosis; Early Detection of Cancer - methods; Endoscopy; Gastric cancer; Gastritis; Genes; Genetic aspects; Health aspects; hsa_circ_000780; Humans; Identification and classification; MicroRNAs; Pathology, Molecular; Polymerase chain reaction; Ribonucleic acid; RNA; RNA, Circular; RNA-directed DNA polymerase; Software; Statistical analysis; Stomach cancer; Stomach Neoplasms - diagnosis; Stomach Neoplasms - genetics; Stomach Neoplasms - pathology; Tumors
• ISSN: 1755-8794; 1755-8794
• DOI: 10.1186/s12920-021-01096-6

The present study aimed to identify a specific circular RNA (circRNA) for early diagnosis of gastric cancer (GC). Totally 82 patients with GC, 30 with chronic nonatrophic gastritis and 30 with chronic atrophic gastritis were included in this study. Four of the 82 GC patients were selected for screening. Total RNA from malignant and adjacent tissue samples was extracted, and circRNAs in four patients were screened. According to the screening results, the eight most upregulated and downregulated circRNAs with a statistically significant association with GC were identified by real-time fluorescent quantitative polymerase chain reaction (PCR). Then, the most regulated circRNA was selected for further sensitivity and specificity assessments. CircRNA expression was examined by quantitative reverse transcriptase PCR in 78 GC (21 and 57 early and advanced GC, respectively) and adjacent tissue samples, as well as in gastric fluid samples from 30 patients with chronic nonatrophic gastritis, 30 with chronic atrophic gastritis, and 78 GC. A total of 445 circRNAs, including 69 upregulated and 376 downregulated circRNAs, showed significantly altered expression in GC tissue samples. Hsa_circ_000780 was significantly downregulated in 80.77% of GC tissue samples, with levels in GC tissue samples correlating with tumor size, tumor stage, T stage, venous invasion, carcinoembryonic antigen amounts, and carbohydrate antigen 19-9 levels. Strikingly, this circRNA was found in the gastric fluid of patients with early and advanced GC. The present study uncovered a new circRNA expression profile in human GC, with hsa_circ_000780 significantly downregulated in GC tissue and gastric fluid specimens. These findings indicate that hsa_circ_000780 should be considered a novel biomarker for early GC screening.